AstraZeneca
AZN
#68
Rank
$250.42 B
Marketcap
$161.47
Share price
-1.67%
Change (1 day)
8.01%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): $6.68

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $6.68. In 2024 the company made an earnings per share (EPS) of $4.54 an increase over its 2023 EPS that were of $3.84.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$6.68
2024$4.5418.23%
2023$3.8481.13%
2022$2.12631.03%
2021$0.29-88.11%
2020$2.44136.89%
2019$1.03-39.41%
2018$1.70-28.27%
2017$2.37-14.37%
2016$2.7724.11%
2015$2.23127.55%
2014$0.98-51.96%
2013$2.04-58.95%
2012$4.97-32.2%
2011$7.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$8.73 30.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$6.66-0.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$3.12-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$29.88 347.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$1.90-71.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$5.68-14.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$1.27-81.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.54-32.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$3.20-52.13%๐Ÿ‡ฌ๐Ÿ‡ง UK